It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
originally posted by: DigitalJedi805
a reply to: MystikMushroom
RIGHT!?
*facepalm*
Go download a fething free web template and copy and paste your text into it for the love of god.
GlaxoSmithKline, NewLink working to bring Ebola vaccines online: WHO
(Reuters) - Both GlaxoSmithKline and NewLink Genetics are working to boost their capacity to make Ebola vaccines, with a goal of a "very significant increase in scale during the first half of 2015", the World Health Organization said on Wednesday.
Even under the best conditions, if the experimental vaccines are proven to be safe and confer protection in clinical trials, a significant number of doses will not be available until late in the first quarter of 2015, the WHO said.
GSK and NewLink are conducting phase 1 trials in healthy volunteers currently or soon in more than 10 sites in Africa, Europe and North America, the WHO said in a statement after hosting a two-day meeting of 70 experts.
Initial safety data was expected by year-end, with phase II trials early next year to generate more data.
"Both companies are working to augment their manufacturing capacity. The goal is a very significant increase in scale during the first half of 2015," the U.N. agency said.
originally posted by: DigitalJedi805
a reply to: PlasticWizard
I'd rather know that they're a real company...
No REAL company ( Note the 3 that I referenced, that still manage to make vaccines? ) has a website of that quality... Period.
originally posted by: MystikMushroom
a reply to: marg6043
Well, look at their location. It must cost a fortune to rent that place out. Maybe they've burned through all their grant money?
That was sarcasm, btw.
originally posted by: MystikMushroom
a reply to: marg6043
Well, look at their location. It must cost a fortune to rent that place out. Maybe they've burned through all their grant money?
That was sarcasm, btw.
His efforts to create an effective vaccine are funded by a $26 million National Institutes of Health grant awarded collaboratively with Profectus BioSciences, Tekmira Pharmaceuticals Corp. and the Vanderbilt University Medical Center.